CNCR Loncar癌症免疫療法ETF基金
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About CNCR Loncar癌症免疫療法ETF基金
The Index tracked by the Fund is the Range Cancer Therapeutics Index, which seeks to achieve the same investment performance as the Index before deducting various fees and expenses. The Fund seeks to invest all or substantially all of its assets in the constituent securities and ADRs that make up the Index. Under normal circumstances, at least 80% of the fund's total assets (excluding any collateral held for securities borrowing) will be invested in the constituent securities of the index.
如何購買 CNCR Loncar癌症免疫療法ETF基金 (CNCR)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 CNCR
透過 RockFlow App 或網頁端搜尋 CNCR，輸入您想要投資的金額，然後點擊確認即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.